Authors: E. Češková; V. Pálenský; S. Skotáková Authors‘ workplace: Psychiatrická klinika LF MU a FN Brno, přednosta prof. MUDr. E. Češková, CSc. Published in: Čes. a slov. Psychiat., , 2004, No. 3, pp. 148-152. Category:
In a view of the fact that in clinical practice we have no antidepressants acting by the nonaminergicmechanism, it is necessary to make the most of possibilities given by available antidepressant. Atfi rst we can positively infl uence compliance by stressing the patient participation on the treatment.The therapy should especially consider which side effects are acceptable for the individual patient.A small probe examining how much information about treatment is given to the patient and howmuch they can decide about treatment shows that there is a great space for improving the actualsituation. Further possibilities are given by the availability of the new galenic forms and specifi cantidepressants.
Key words: nonaminergic mechanisms, information of therapy, galenic formulations ofantidepressants, availability of specifi c antidepressants, participation of patient in decision-making.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
